Auroactive Pharma Profile
Key Indicators
- Authorised Capital ₹ 150.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 100.00 Cr
as on 16-11-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 425.00 Cr
as on 16-11-2024
About Auroactive Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 150.00 Cr and a paid-up capital of Rs 100.00 Cr.
The company currently has active open charges totaling ₹425.00 Cr.
The Key Managerial Personnel (KMP) at Auroactive Pharma Private Limited India are Aravapalli Bhaskar as CFO and Sai Yerramsetti as Company Secretary. Santhanam Subramanian, Venkatanarayana Jayampu, Deepak Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230TG2020PTC138313
- Company No.
138313
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2020
- Date of AGM
05 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Auroactive Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aravapalli Bhaskar  | CFO | 21-Mar-2022 | Current |
| Sai Yerramsetti | Company Secretary | 07-Nov-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santhanam Subramanian | Director | 01-Jul-2023 | Current |
| Venkatanarayana Jayampu | Additional Director | 07-Nov-2024 | Current |
| Deepak Singh | Director | 01-Feb-2023 | Current |
| Mylandlahalli Ashwini | Director | 12-Jun-2024 | Current |
Financial Performance and Corporate Structure Insights of Auroactive Pharma.
Auroactive Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Auroactive Pharma?
In 2023, Auroactive Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apitoria Pharma Private Limited
Active 6 years 11 monthsSanthanam Subramanian and Mylandlahalli Ashwini are mutual person
Apl Healthcare Limited
Active 17 years 11 monthsVenkatanarayana Jayampu and Mylandlahalli Ashwini are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 05 Oct 2023 | ₹425.00 Cr | Open |
How Many Employees Work at Auroactive Pharma?
Auroactive Pharma has a workforce of 105 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auroactive Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auroactive Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
